Page last updated: 2024-09-04

butylscopolammonium bromide and Sclerosis, Systemic

butylscopolammonium bromide has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gregersen, H; Hendel, L; Storkholm, JH; Villadsen, GE; Vilstrup, H1

Other Studies

1 other study(ies) available for butylscopolammonium bromide and Sclerosis, Systemic

ArticleYear
Impedance planimetric characterization of esophagus in systemic sclerosis patients with severe involvement of esophagus.
    Digestive diseases and sciences, 1997, Volume: 42, Issue:11

    Topics: Adult; Aged; Butylscopolammonium Bromide; Cholinergic Antagonists; Esophageal Diseases; Esophagus; Female; Humans; Male; Manometry; Middle Aged; Peristalsis; Scleroderma, Systemic

1997